CELLULAR GOODS PLC
CBX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BK964W87
- LEI:
- 213800IXPX4Z2MKX2U28
- Country:
- United Kingdom
- Address:
- 9TH FLOOR, WC2B 5DG LONDON
- Website:
- https://cellular-goods.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Cellular Goods PLC develops wellness products using biosynthetic cannabinoids.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-02 08:00 |
Share Issue/Capital Change
Subscription to raise £250,000
|
English | 28.9 KB | |
| 2025-05-30 14:59 |
Earnings Release
Interim results
|
English | 195.4 KB | |
| 2025-05-29 18:51 |
Share Issue/Capital Change
Cancellation of Directors’ Subscription
|
English | 11.5 KB | |
| 2025-05-27 12:04 |
Share Issue/Capital Change
Replacement-Cel AI Completes Fundraise of £500,000
|
English | 35.1 KB | |
| 2025-05-23 19:01 |
Capital/Financing Update
Cel AI Completes Fundraise of £500,000
|
English | 34.0 KB | |
| 2025-02-25 16:46 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 8.8 KB | |
| 2025-02-17 08:00 |
Directors' Dealings
Changes in Board Composition - Grant of Warrants
|
English | 53.9 KB | |
| 2025-01-31 10:26 |
General Meeting Notice
Notice of AGM
|
English | 10.4 KB | |
| 2024-12-30 08:00 |
Annual Report
Annual results
|
English | 572.7 KB | |
| 2024-06-28 08:00 |
Regulatory News Service
Changes in board composition
|
English | 16.2 KB | |
| 2024-06-18 15:23 |
Regulatory News Service
Changes in Board Composition
|
English | 94.6 KB | |
| 2024-06-14 19:09 |
Regulatory News Service
Changes in Board Composition
|
English | 16.2 KB | |
| 2024-05-28 08:00 |
Earnings Release
Interim results
|
English | 180.8 KB | |
| 2024-04-30 08:00 |
Regulatory News Service
Board change
|
English | 11.3 KB | |
| 2024-03-18 08:00 |
Directors' Dealings
Director’s Dealings
|
English | 22.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
OSE Immunotherapeutics | France | OSE | |
|
Ovoca Bio Plc | Ireland | OVXA | |
|
Oxford Biomedica PLC | United Kingdom | OXB | |
|
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | United Kingdom | OCTHF | |
|
Oxurion NV | Belgium | OXUR | |
|
PCI Biotech Holding | Norway | PCIB | |
|
Pentixapharm Holding AG | Germany | PTP | |
|
Perpetua Medical AB | Sweden | PERP | |
|
PharmaLundensis AB | Sweden | PHAL | |
|
Pharma Mar S.A. | Spain | PHM |